Literature DB >> 14079015

PATHOLOGY OF EXPERIMENTAL RESPIRATORY ANTHRAX IN MACACA MULATTA.

C A GLEISER, C C BERDJIS, H A HARTMAN, W S GOCHENOUR.   

Abstract

Entities:  

Keywords:  ANTHRAX; EXPERIMENTAL LAB STUDY; LUNG DISEASES; LUNG DISEASES, PARASITIC; MITES; MONKEYS; PATHOLOGY

Mesh：

Year:  1963        PMID： 14079015      PMCID： PMC2095253     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  4 in total

1.  Experimental parenteral anthrax in Macaca mulatta.

Authors:  C C BERDJIS; C A GLEISER; H A HARTMAN
Journal:  Br J Exp Pathol       Date:  1963-02

2.  Human inhalation anthrax. A report of three fatal cases.

Authors:  W S ALBRINK; S M BROOKS; R E BIRON; M KOPEL
Journal:  Am J Pathol       Date:  1960-04       Impact factor: 4.307

3.  Experimental inhalation anthrax in the chimpanzee.

Authors:  W S ALBRINK; R J GOODLOW
Journal:  Am J Pathol       Date:  1959 Sep-Oct       Impact factor: 4.307

4.  Lung mites; pulmonary acariasis as an enzootic disease caused by Pneumonyssus simicola in imported monkeys.

Authors:  J R INNES; M W COLTON; P P YEVICH; C L SMITH
Journal:  Am J Pathol       Date:  1954 Jul-Aug       Impact factor: 4.307
  4 in total
  16 in total

1.  Discussion.

Authors:  H N Glassman
Journal:  Bacteriol Rev       Date:  1966-09

2.  Sverdlovsk revisited: modeling human inhalation anthrax.

Authors:  Dean A Wilkening
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-05       Impact factor: 11.205

3.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 4.  Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines.

Authors:  Andrew J Phipps; Christopher Premanandan; Roy E Barnewall; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

5.  Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.

Authors:  L Mark Kao; Karen Bush; Roy Barnewall; James Estep; Frederic W Thalacker; Pamela H Olson; George L Drusano; Neil Minton; Shuchean Chien; Alex Hemeryck; Michael F Kelley
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

6.  Causes of the failure of antibiotic prophylaxis of inhalation anthrax and clearance of the spores from the lungs.

Authors:  J Vancurík
Journal:  Folia Microbiol (Praha)       Date:  1966       Impact factor: 2.099

7.  Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection.

Authors:  David E Lowe; Stephen M C Ernst; Christine Zito; Jason Ya; Ian J Glomski
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax.

Authors:  Cynthia A Rossi; Melanie Ulrich; Sarah Norris; Douglas S Reed; Louise M Pitt; Elizabeth K Leffel
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

9.  The physiologic responses of Dutch belted rabbits infected with inhalational anthrax.

Authors:  William S Lawrence; Jason M Hardcastle; Douglas L Brining; Lori E Weaver; Cindy Ponce; Elbert B Whorton; Johnny W Peterson
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

10.  Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001.

Authors:  Kevin S Griffith; Paul Mead; Gregory L Armstrong; John Painter; Katherine A Kelley; Alex R Hoffmaster; Donald Mayo; Diane Barden; Renee Ridzon; Umesh Parashar; Eyasu Habtu Teshale; Jennifer Williams; Stephanie Noviello; Joseph F Perz; Eric E Mast; David L Swerdlow; James L Hadler
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.